Fortis Group Advisors, LLC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 1815183 WESTWOOD, NJ

Position in LXRX

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$120,000

+$42,000 QoQ

Shares Held

50,000

0.0% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#70

of 148 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $498,707 across 4 Biotechnology names. LXRX ranks #2 (24.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	1,105	$270,470
2	LXRX	Lexicon Pharmaceuticals, Inc. This page	50,000	$120,000
3	PGEN	Precigen, Inc.	18,966	$108,106
4	CRBP	Corbus Pharmaceuticals Holdings, Inc.	14	$131

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$120,000	50,000	0.0%	Shares	Sole	2026-07-24
2026-03-31	$78,000	50,000	0.0%	Shares	Sole	2026-05-08
2025-12-31	$57,500	50,000	-13.5%	Shares	Sole	2026-02-06
2025-09-30	$78,030	57,800	0.0%	Shares	Sole	2025-11-07
2025-06-30	$54,910	57,800	+52.9%	Shares	Sole	2025-08-08
2025-03-31	$17,388	37,800	—	Shares	Sole	2025-05-02
No filing history on record for this holder in this stock.